e-learning
resources
Vienna 2009
Monday, 14.09.2009
Hot topics in molecular pathology and functional genomics of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
NADPH oxidases are regulated in a mouse model of tobacco smoke induced COPD
M. Seimetz, N. Parajuli, M. Roth, R. Schermuly, A. Ghofrani, W. Seeger, F. Grimminger, N. Weissmann (Giessen, Germany)
Source:
Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD
Session:
Hot topics in molecular pathology and functional genomics of COPD
Session type:
Oral Presentation
Number:
2790
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Seimetz, N. Parajuli, M. Roth, R. Schermuly, A. Ghofrani, W. Seeger, F. Grimminger, N. Weissmann (Giessen, Germany). NADPH oxidases are regulated in a mouse model of tobacco smoke induced COPD. Eur Respir J 2009; 34: Suppl. 53, 2790
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Regulation of glutaredoxins by cigarette smoke
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009
Acute cigarette smoke induced airway neutrophilia in a mouse model is ROS dependent
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Mitochondria are essential in cigarette smoke induced ROS generation
Source: Annual Congress 2008 - Airway cell biology
Year: 2008
Reversible inhibition of mitochondrial complex IV activity in PBMC following acute smoking
Source: Eur Respir J 2004; 23: 214-218
Year: 2004
Cigarette smoke in mice, rats and guinea-pigs: value to the study of pathogenic factors involved in COPD
Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma
Year: 2005
Mitochondrial dehydrogenase activity as a measure of tobacco smoke toxicity
Source: Annual Congress 2007 - The versatile aspects of nicotine addiction
Year: 2007
Expression of superoxide dismutases in cigarette smoke induced bronchitis is modulated by ambroxol
Source: Eur Respir J 2003; 22: Suppl. 45, 79s
Year: 2003
Eucalyptol reduced inflammation and oxidative stress on mouse lungs exposed to long and short-term cigarette smoke
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
COPD fibroblasts are more responsive to cigarette smoke exposure
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
A comparison of anti-inflammatory compounds in a steroid-insensitive mouse tobacco smoke model
Source: Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases
Year: 2012
Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Role of highly reactive aldehydes in cigarette smoke induced airway inflammation
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Inhibition of β-adrenoceptors alleviated mucus secretion and emphysema in cigarette smoke exposed rat model
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Alveolar changes in a chronic tobacco smoke inhalation COPD mouse model
Source: Annual Congress 2008 - The biology of smoking and COPD
Year: 2008
PDE4 inhibition prevents corticosteroid-resistant lung inflammation induced by cigarette smoke exposure in mice
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009
Blocking IL-20 pathway limits the development of bacteria induced exacerbation in mice chronically exposed to cigarette smoke.
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Regulation of immunoproteasomes by cigarette smoke
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012
Cigarette smoke exposure in mice leads to a loss of reversible cysteine oxidations PSSG and PSNO in lung
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Cigarette smoke disrupts mitochondrial function by acute blockage of the respiratory chain
Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research
Year: 2005
The interaction of cigarette smoke and allergens in a mouse model of asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 736s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept